Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**povidone-iodine + lidocaine** is an ophthalmic topical combination product being developed as a **thermoresponsive gel depot** for **pre-intravitreal injection antisepsis and anesthesia**. The formulation combines **lidocaine**, a local anesthetic that decreases ocular surface sensitivity, with **povidone-iodine**, a broad-spectrum antiseptic that releases free iodine and kills microorganisms on the ocular surface. It is administered as a liquid into the lower fornix and transitions at body temperature into a stable gel, enabling single-step delivery of anesthesia and antisepsis before intravitreal injection procedures for retinal diseases. Based on the provided context, the product is an investigational combined delivery system designed to avoid the reduced antiseptic efficacy that can occur when lidocaine gel and povidone-iodine are applied sequentially.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + lidocaine.